The levels of expression of antigen expression genes TAP1, TAPBP, B2M, and HLA-A (the human ortholog of the mouse H2-D1 gene) were shown to predict longer patient survival in colon and ovarian cancers (Figure 7, A–D). This evidence concerns the gene HLA-A and ovarian carcinoma.